Emcure Rockets as USFDA Clears Inspection; Key Pharma and Corporate Stocks React to Q4 Results
Stock-specific rallies and declines are expected across Dalal Street as investors digest a fresh batch of June quarter earnings reports and critical corporate developments. The concluding leg of the earnings season is driving sharp movements, with brokerage upgrades and key company announcements shaping trading patterns today.Emcure’s USFDA VAI Sparks 3% Rally in Pharma Sector
Emcure Pharmaceuticals saw its share price climb nearly 3 percent after reporting favorable news regarding a crucial regulatory inspection. The company received the Establishment Inspection Report from the USFDA for its formulations facility located in Sanand, Gujarat. This inspection, conducted between May 6 and May 15, 2026, was closed with a Voluntary Action Indicated (VAI) status classification.The positive news resonated strongly across the pharmaceutical sector. Akums Drugs and Pharmaceuticals gained 3 percent after posting impressive results. The company reported a 56.1% year-on-year surge in net profit to ₹101 crore, up from ₹64.7 crore. Revenue also saw a healthy growth of 13.9%, reaching ₹1,166.6 crore from ₹1,024 crore.
Anant Raj also managed to rise nearly 1 percent following its earnings release. The company announced a 18.9% year-on-year increase in net profit, which reached ₹149.6 crore compared to ₹125.9 crore in the previous period. Revenue grew 6.6%, increasing to ₹631.4 crore from ₹592.4 crore.
Corporate Stocks React to Mixed Earnings and Strategic Deals
The broader corporate sector showed mixed sentiment as investors absorbed varying financial performances and strategic announcements. Titan Company saw a positive reaction, gaining 1.5 percent on its results. The company reported a substantial 62.9% year-on-year jump in net profit, which hit ₹1,777 crore from the previous ₹1,091 crore. Revenue for Titan increased by 29.3%, reaching ₹21,356 crore from ₹16,523 crore.Power Finance Corporation (PFC) stock slipped 3 percent despite reporting a rise in net profit. PFC posted a 2.1% year-on-year increase in net profit, amounting to ₹7,012 crore up from ₹6,866.3 crore. However, the stock reacted negatively as net interest income saw a decline of 3.3%, falling to ₹10,696.4 crore from ₹11,061.4 crore.
RITES experienced a downturn, with shares falling more than 1 percent. This reaction came after the company signed a Memorandum of Understanding (MOU) with Hindustan Petroleum Corporation (HPCL). The MOU outlines RITES’ role in providing consultancy services for railway siding infrastructure development across HPCL’s facilities.
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.